chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Household exposure to COVID (2 family members tested positive on 2/17.)  She had her second dose of the Moderna vaccine on 2/5/21. She started having COVID symptoms on 2/20/21 and tested positive on 2/23/21.   She is a healthcare worker (works as professional interpreter in a primary health care clinic and dental office)
For 3.5 weeks I experienced headaches, brain fog and join pain. The headaches and brain fog have subsided but I am still experiencing joint pain. which has radiated from my shoulders to my elbows and now my back.
Information has been received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. There was no medical history or concurrent condition reported. On unspecified dates since 08-OCT-2015, the unspecified patients were vaccinated with doses of RECOMBIVAX HB (lot # L004754, expiration date 10-NOV-2016 and lot # L014418, expiration date 13-APR-2017) (dosage, strength and route were not reported), which were exposed to temperatures outside of the recommended range. There was no concomitant medication reported. No adverse experience had been reported. This is one of several reports from the same reporter. Additional information has been requested.
Fatigue; Body Aches; fever; redness in the IS; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Body Aches), PYREXIA (fever) and VACCINATION SITE ERYTHEMA (redness in the IS) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Body Aches), PYREXIA (fever) and VACCINATION SITE ERYTHEMA (redness in the IS). On 15-Feb-2021, FATIGUE (Fatigue), MYALGIA (Body Aches) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (redness in the IS) had not resolved.            No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Days 1-3: flushed, temp of 99-100, extreme pain in joints and muscles, dizziness, weakness, elevated blood sugar (400s), elevated blood pressure, couldn't stay awake.  Treated with OTC cold/flu meds, no appetite~  Days 4-13 same plus wheezing cough, difficulty catching breath, difficulty talking, difficulty comprehension, focus, etc. Low oxygen level. Went to the ER on Day 8 with all of the above. Given oxygen and IV (of what another person had--as was my understanding), prescriptions: Promethazine-DM;methylPREDNISolone; albuterol;azithromycin. Currently--still difficulty breathing, coughing, difficulty focus, very weak.   Treatment: walking, lots of water, cough syrup and albuterol
severe fatigue and brain fog x 3 days; on 3rd day it was the most severe and felt very strange, "trippy", not hallucinating but kind of an out of body sensation. felt similar to laughing gas but without the laughing. Also felt similar to when I had Covid in May 2022, so I did a Covid test and it was negative. Felt normal on day 4.
Pt. states had no redness or swelling or pain at shot of injection right after shot, but noticed soreness lateral side of (L) deltoid muscle and has continued until late. Dr. prescribed fish oil 2-4 po, daily. RTO if no better 6 weeks.
PPSV23 ordered and delivered on 11/06/2015 - then same provider ordered a "booster" on 01/04/2016.  Both were delivered in the left deltoid. Patient states experienced severe erythema and pruritus.  Erythema was localized around the vaccine sight the first night but severe and then spread down the arm and caused slight bruising.  Patient also reports numbness and tingling in the tongue and lips (although there is previous mention of this in patients chart so may not be related, but onset of this incident is suspicious). Patient given oral steroids today and will return in two days for further evaluation.
Child suddenly turned sheet white, and started complaining his head hurt. He sat staring into space, seemingly unaware periodically, and moaning between periods of staring into space, which we believe may have been small seizures, for the majority of the rest of the day. Within two hours his temperature had climbed from normal to 104.5 and was still going up. Tylenol was administered and brought the temperature down. His stutter, which had been gradually improving, has become much worse in the days following, and he has begun wetting himself without realizing it has happened, after being reliably toilet trained for over a year and a half.
Diarrhea; nausea and vomiting; nausea and vomiting; rash on her right arm, like a hive or whelp; Fever; Headache; really sore right arm; right arm felt numb; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received the first dose of BNT162B2 (Pfizer COVD 19 vaccine), lot number: EL0142, via an unspecified route of administration on 07Jan2021 17:00 at single dose in right arm for COVID-19 immunisation. Medical history included blood pressure abnormal, had a cough from having COVID 19 on 16Dec2020, cough was ongoing and unknown for COVID-19. Concomitant medication included amlodipine from an unspecified date (taking for 2 years) and ongoing at 10mg once daily by mouth for blood pressure abnormal. No other vaccines were administered on same date and no prior vaccinations (within 4 weeks). Registered nurse (patient) was calling regarding Pfizer COVID 19 vaccine. Reported she received the first dose last Wednesday 07Jan2021 17:00 in the right arm. Reported she noticed the next day (08Jan2021) fever and a headache. On 08Jan2021, Friday she had a really sore right arm and her right arm felt numb. On 09Jan2021, Saturday, she experienced nausea and vomiting and also noticed a rash on her right arm, like a hive or whelp. On 10Jan2021 Sunday, again with the fever, nausea, vomiting and she had diarrhea. Today she stated she woke up a new woman. She feels felt with no fever and her arm was better. She still had a cough from having COVID 19 on 16Dec2020. Stated she was used to coughing.  Added she treated the fever with Tylenol 1000mg. Stated she didn't remember exactly but she took a little everyday starting on Thursday the day after the vaccine. Stated she was unsure if she would have the next dose. The events didn't require a visit to physician office or emergency room. The outcome of fever was recovered on 10Jan2021, of Headache, sore arm, rash on right arm, nausea and vomiting was recovered on 11Jan2021, of arm numb was recovered on 09Jan2021, of diarrhea was recovering. Serious criteria for fever was reported as yes, medical significant, for Headache, sore arm, arm numb and Diarrhea was non-serious, for rash on right arm, nausea and vomiting was unspecified.; Sender's Comments: Based on the compatible time association, the event fever is possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
redness like the size of silver dollar; itching at injection site; hard to the touch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness like the size of silver dollar), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE INDURATION (hard to the touch at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness like the size of silver dollar), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE INDURATION (hard to the touch at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness like the size of silver dollar), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE INDURATION (hard to the touch at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Intense back pain; muscle pain; more like a flu type achy pain; This is a spontaneous report received from contactable reporter(s) (Pharmacist).  A 73-year-old female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 08Nov2023 as 0.5 ml, single (Lot number: HL9687, Expiration Date: Mar2025) at the age of 73 years intramuscular for immunisation; for immunisation. The patient's relevant medical history included: "Chronic respiratory disease" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE; DULOXETINE; LEVOTHYROXINE; OMEPRAZOLE; PREMARIN; PRIMIDONE; SYMBICORT; TRAZODONE. The following information was reported: BACK PAIN (non-serious) with onset 08Nov2023, outcome "not recovered", described as "Intense back pain"; INFLUENZA LIKE ILLNESS (non-serious) with onset 08Nov2023, outcome "unknown", described as "more like a flu type achy pain"; MYALGIA (non-serious) with onset 08Nov2023, outcome "unknown", described as "muscle pain". Therapeutic measures were taken as a result of back pain, myalgia, influenza like illness. Additional information: patient called last night to state that about a half hour after the shot she started to experience back pain, midline, called this morning said that it was intense back pain. She said she have looked and saw about muscle pain, and the reporter said typically that's myalgia more like a flu type achy pain that you would see in the muscles, not a sharp pain in an area but she still said it happened after the shot. It's not something that she normally gets, and the reporter said that's not something that they would typically see, but the reporter can and will report it and let them know. The reporter thought that the treatment was just Tylenol.  The information on the batch/lot number for rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
Flu-like symptoms; Body aches; Lethargic; This is a spontaneous report from a contactable consumer. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 19Mar2021 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination, the patient was not diagnosed for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the patient experienced flu-like symptoms, body aches and lethargic but no fever or cough. It went away within 24 hours and patient felt completely fine, even ran 9 miles. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of flu-like symptoms, body aches and lethargic was resolved on an unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
s/s: 1)Redness-none, 2)Swelling-none, 3)pain-mild @ injection booister site right deltoid only if arm lifted or push on site,  mild, last 3 days, 4)fever-none, 5)fatigue-mild/occassionally moderate, less energy, even walking, gradually improved after 30 hrs past injection, none after 48 hrs, 6)headache-very mild for 2 hrs in first 6 hrs after shot, none thereafter, 7)chills-none, 8)vomit-none, )9)diarrhea-none, 10)joint pain-lower back mild 6 hrs during hrs 18-30 after the injection, none thereafter, 11)antipyretic-none, 12)other-nerve numbness and tingling above upper lip and below lower lip 15 min duration mild after 6 hrs after injection, resolved, no cyanosis, none thereafter.  Numbness/tingling around lips I have had during 6 other Nora virus infections lasting moderately  2 hrsover the past 30 years, not with this Moderna injection.
Light headed, fainting x2. tx; O2 per mask (4L) rest/Lay down cool compress on forehead
pt recv vax 26SEP96 & 1 to 2 days p/vax pt exp profuse sweating, weakness, feeling hot, tired, & fatigue;6OCT96 pt recovered from exp;
Information has been received from an office manager at the physician's office, concerning a female patient, who was vaccinated with first, second and third doses of GARDASIL (dose, route, lot # not reported).  The office manager reported that the patient completed her GARDASIL vaccination series a couple of months ago and started experiencing hip pain and headaches.  At the time of the report, the patient had not recovered.  Follow up information was received from the Registered Nurse on 23-DEC-2008 which reported: The patient was vaccinated with three doses of GARDASIL on 19-SEP-2007, 29-NOV-2007 and 03-APR-2008 respectively.  The patient experienced hip pain, headaches, and stomach pain and that were all still ongoing.  The patient also experienced fatigue but that has resolved.  Follow up information has been received from a Registered Nurse on 30-DEC-2008 which reported that the lot number that was administered was: 660387/19670.  The patient was administered the vaccine at her pediatrician's office.  The patient was also administered varicella virus vaccine live (Oka/Merck) (MSD) and hepatitis B virus vaccine rHBsAg (yeast) (MSD) on the same day the patient received her third dose of GARDASIL.  Additional information has been requested. 2/4/09-records received-presented on 11/17/08 with C/O run down, tired. 11/24/08 still very fatigued, dizzzy, occasional. 12/16/08 C/O headache. Possibility treated by another physician prior to presenting on 11/17/08.  2/23/09-records received-office visit 1/20/09-C/O headache, neck in pain for past 3 months. Holter monitor supraventricular ectopic beats noted. 12/30/08 increasing headaces.
Pt. recieved vaccine 12 hours past expiration. MD contacted pt. No adverse event. pt. declined revaccination
I gave Pt his vaccine at approximately 4:10pm and asked him to wait 15 minutes before leaving. At approximately 4:15pm Pt's head went back and forth hitting his head on the wall, then he passed out. Upon hearing  there was an accident , I immediately went to the patients side, where I found him sweating and his heart racing. I asked Pt was he ok and he replied that his heart was racing. We call 911 and waited with Pt until they arrived. At approximately 4:30pm the EMS arrived and evaluated the patient. By 4:40pm, the EMS left and requested Pt to stay until his ride came to assist him.
Patient became dizzy, hypertensive (213/113), flushed, and nauseated post vaccination
Patient has severe underlying fibrotic lung disease. Evaluations in the past suggested possibly hypersensitivity pneumonitis. There was concern she might also have severe pulmonary fibrosis. She has been on Ofev and oxygen at home. Her baseline oxygen is 5 Lat rest and 10 L with activity. Patient developed symptoms 1/17/2022. She was+ for COVID 1/24/2022. At that time chest x-ray showed severe pulmonary fibrosis. CT chest 1/25/2022 with extensive pulmonary fibrosis and bibasilar infiltrates as well as ascending aortic aneurysm 4.1 cm and pulmonary artery dilation consistent with pulmonary hypertension. She has been on a burst of high-dose Solu-Medrol  per pulmonary. Patient is now transitioning to prednisone. She did receive tocilizumab.  Patient required bipap, family decided to discharge on hospice.  Patient expired on 2/4/22.
73 year old female client told RN on 3/22 that on March 14th, after getting 2nd dose of Pfizer vaccine (EN 16203). On March 15th morning, she got Bell's Palsy on her R face. Her doctor sent her to ER and the doctor prescribed her Prednisone (20 mg tid) and Valacyclovir (1 g tid) for 7 days. After one week, client was slowly recovered.
3/4/2021 Moderna Shot #1 received 3/27/2021 Tinnitus in both ears began that night  4/1/2021 Moderna Shot #2 received 4/3/2021 Woke up and tinnitus was gone through the day but returned that night and continues to this day, 4/8/2021 4/5/2021 Went to Urgent Care and there is no ear or sinus infection.  Ears are clear.  At first I didn't think the tinnitus was connected to the initial Moderna shot but I now believe it's related.     I did get sick with the Moderna shot #2 with a 102.0 fever and painful aches from my arms to my toes and feet.  The fever only lasted 24 hours but the aches/pain lasted for at least a week.   I can't help but wonder if the Moderna shot #2 added to the tinnitus and maybe that's why it continues a week after Moderna shot #2.   I am a very healthy and active 65 year old and have never had tinnitus.  I am not on any new medications and have had no other vaccines or illnesses during this period.  There have been no changes in my life from Moderna shot #1 was received.  I'm just hoping this is a side effect that goes away within a few more days or weeks.  It is extremely irritating and sleep does not come easy.   This should not be considered a mild or temporary side effect if it lasts for weeks and hopefully not for months.   I'm hoping the tinnitus goes away as it is extremely irritating.
NURSE COLLECTING DEMOGRAPHIC INFO DID NOT CATCH THAT DOB WAS UNDER 18 YRS. NURSE ADMINISTERING SHOT OVERHEARD MOTHER OF PATIENT MENTION HER AGE AS 15 YRS AFTER INJECTION WAS GIVEN. PATIENT HAD STATED THAT SHE NEEDED THE VACCINE FOR A NEW JOB. NURSES INSIDE CLINIC HAD REFERRED HER TO THE OUTSIDE DRIVE THRU CLINIC, WHICH ONLY VACCINATES 18 AND OVER.
pt brought by EMS to a local HCF ED admitted with Covid from another HCF. Hx of Parkinson's and dementia concerned for PE
Presented with SOB, cough x 1 week; Covid + ED; admitted to ICU with Covid PNA; tx with zithromax, rocephin, steroids, remdesivir, singulair, zinc, maxipime, supplemental O2; intubated 9/11; IgG infusion;currently remains intubated with worsening renal function; on pressors; critically ill;  After discussions with the husband, he expressed that she would not have wanted dialysis. Palliative care assisted in family meetings and the family elected to transition to comfort measures. She was made DNR and therapy was discontinued. She was declared deceased on 9/29/21 at 11:09.
Complained nausea and vomiting on day 5, extreme fatigue, decreased appetite, insomnia, occasional dizziness, "overall-not feeling right". Complained of severe muscle spasms in right shoulder the next week resulting in visit to chiropractor and therapy for 1 week. Denies any local reaction to vaccine. Denies any increased temp.
has a second dose of the vaccine this 09Mar and having a appointment for 01Mar of Prolia Shot; she got experienced bone hurts, headache and taste buds change; she got experienced bone hurts, headache and taste buds change; she got experienced bone hurts, headache and taste buds change; This is a spontaneous report from a contactable consumer or other non hcp.  A female patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single DOSE for covid-19 immunisation. The patient medical history concomitant medications were not and reported. It was reported that, Caller called and said that she got the 1st dose of Covid 19 Vaccine and has a second dose of the vaccine this 09Mar and having a appointment for 01Mar of Prolia Shot, Caller also mentioned that she got experienced bone hurts, headache and taste buds change. The outcome of the events was unknown on an unspecified date.  Information on the lot/batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Rash; This case was reported by a physician via call center representative and described the occurrence of rash in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a month after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was recovering/resolving.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The reporter stated that, the patient developed a rash and had developed more within the last 3 to 4 days from the time of reporting. The reporter stated that the patient did not know the exact date of the vaccination nor the expiration date and lot number.
Red, warm, itchy rash at injection site and below injection, moderate to severe body pain, severe migraine, fever between 99.9-102F, fatigue, loss of appetite for ~2 days so far.
After initial two days of side effects of temp and fatigue, nausea, continued side effects of extreme fatigue, nausea low grade temp for ten days, fatigue got worse; resulting in extreme shortness of breath. i went to the emergency room where i was diagnosed with AFIB. I spent 6 days in hospital. No previous condition of AFIB. An exam and physical in July did not reveal any health issues.
Information has been received from a physician concerning a 40 year old female patient with breast cancer, hepatitis c and leukocytosis and a history of splenectomy who in approximately October 2009, was vaccinated with a second dose of PNEUMOVAX 23 (Lot # not provided). The physician stated that the patient received the second dose of PNEUMOVAX 23 one month ago and soon afterward developed a red spot and a temperature of 102 degrees. It was not specified if the red spot was at the injection site or not. The patient was admitted to the hospital where was given an intravenous unspecified antibiotic, and soon afterward she recovered. Follow up information has been received from the physician concerning this patient. It was reported that the patient was 46 year old (previously reported as 40 years old). The vaccine was administered on 20-OCT-2009, IM left deltoid (Lot # unknown) at 12:15 pm. Additional information is not expected.